ValuEngine upgraded shares of Mallinckrodt (NYSE:MNK) from a hold rating to a buy rating in a research note released on Tuesday morning, ValuEngine reports.

A number of other research analysts have also recently commented on MNK. Canaccord Genuity decreased their target price on shares of Mallinckrodt from $37.00 to $22.00 and set a buy rating on the stock in a research report on Friday, June 14th. Jefferies Financial Group set a $2.00 target price on shares of Mallinckrodt and gave the company a hold rating in a research report on Friday, September 6th. Berenberg Bank reaffirmed a sell rating and issued a $5.00 target price (down previously from $10.00) on shares of Mallinckrodt in a research report on Tuesday, May 21st. Mizuho decreased their target price on shares of Mallinckrodt from $22.00 to $13.00 and set a neutral rating on the stock in a research report on Tuesday, May 28th. Finally, SunTrust Banks decreased their target price on shares of Mallinckrodt to $7.00 and set a positive rating on the stock in a research report on Monday, August 12th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock has an average rating of Hold and a consensus target price of $10.19.

Shares of MNK stock traded up $0.13 on Tuesday, hitting $3.12. 161,696 shares of the stock traded hands, compared to its average volume of 11,905,633. The firm’s 50-day moving average price is $4.57 and its two-hundred day moving average price is $12.66. The company has a debt-to-equity ratio of 1.57, a quick ratio of 0.57 and a current ratio of 0.78. The stock has a market capitalization of $325.95 million, a PE ratio of 0.38, a PEG ratio of 0.04 and a beta of 2.42. Mallinckrodt has a twelve month low of $1.43 and a twelve month high of $32.50.

Mallinckrodt (NYSE:MNK) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.10 by $0.43. The firm had revenue of $823.30 million for the quarter, compared to analysts’ expectations of $817.55 million. Mallinckrodt had a negative net margin of 111.46% and a positive return on equity of 18.96%. The company’s revenue was down .3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.16 EPS. On average, equities research analysts anticipate that Mallinckrodt will post 8.48 EPS for the current fiscal year.

Several institutional investors and hedge funds have recently modified their holdings of MNK. Parallel Advisors LLC lifted its position in shares of Mallinckrodt by 1,239.3% during the second quarter. Parallel Advisors LLC now owns 3,000 shares of the company’s stock worth $28,000 after purchasing an additional 2,776 shares in the last quarter. Coastal Capital Group Inc. acquired a new stake in shares of Mallinckrodt during the second quarter worth about $31,000. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lifted its position in shares of Mallinckrodt by 151.0% during the second quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 9,173 shares of the company’s stock worth $84,000 after purchasing an additional 5,519 shares in the last quarter. Quantamental Technologies LLC acquired a new stake in shares of Mallinckrodt during the second quarter worth about $84,000. Finally, Teza Capital Management LLC acquired a new stake in shares of Mallinckrodt during the second quarter worth about $92,000.

About Mallinckrodt

Mallinckrodt plc, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands, and Specialty Generics and Amitiza.

Further Reading: Initial Coin Offering (ICO)

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Mallinckrodt (NYSE:MNK)

Receive News & Ratings for Mallinckrodt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mallinckrodt and related companies with MarketBeat.com's FREE daily email newsletter.